Contact
searchSearch
HMP Global

News

Collagen and vitamin drop skin cell
News
HHS Outlines Conditional Enforcement Discretion for 6 Compounded Peptides
10/29/2026
Coleen Stern, MA
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and...
10/29/2026
The Dermatologist
dermatitis
News
Atopic Dermatitis Diagnosis Requires Careful Differentiation From Inflammatory, Infectious, and Systemic Conditions
10/28/2026
Jessica Garlewicz
Accurate diagnosis of atopic dermatitis requires careful differentiation from inflammatory, infectious, autoimmune, and neoplastic conditions that may present with overlapping clinical features.
Accurate diagnosis of atopic dermatitis requires careful differentiation from inflammatory, infectious, autoimmune, and neoplastic conditions that may present with overlapping clinical features.
Accurate diagnosis of atopic...
10/28/2026
The Dermatologist
dermatitis
News
Staphylococcus aureus Identified as Key Contributor to Atopic Dermatitis Pathogenesis
10/28/2026
Jessica Garlewicz
Although the role of S. aureus in atopic dermatitis was previously debated, accumulating evidence has established its contribution to disease pathophysiology and associated morbidity.
Although the role of S. aureus in atopic dermatitis was previously debated, accumulating evidence has established its contribution to disease pathophysiology and associated morbidity.
Although the role of S. aureus...
10/28/2026
The Dermatologist
dermatitis
News
Atopic Dermatitis Epidemiology Highlights Lifelong Disease Burden and Diverse Clinical Trajectories
10/28/2026
Jessica Garlewicz
The review examined epidemiologic findings from the past decade that have expanded understanding of atopic dermatitis as a chronic, heterogeneous condition.
The review examined epidemiologic findings from the past decade that have expanded understanding of atopic dermatitis as a chronic, heterogeneous condition.
The review examined...
10/28/2026
The Dermatologist
cream
News
Behenic Acid and Ceramide Creams Accelerate Skin Barrier Recovery
10/13/2026
Coleen Stern, MA
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid (BA) or ceramide (CER) accelerated recovery of experimentally damaged skin, suggesting that both lipid components may support topical formulations designed to restore barrier function.
Creams containing behenic acid...
10/13/2026
The Dermatologist
News
Pediatric Psoriasis Review Highlights Diagnostic Challenges, Expanding Role of Biologics
10/07/2026
Jessica Garlewicz
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can substantially affect quality of life and contribute to cumulative life course impairment, but evidence guiding its management remains limited compared with adult disease.
Pediatric psoriasis can...
10/07/2026
The Dermatologist
News
Psoriasis Reframed as Systemic Disease With Metabolic and Hepatic Implications
10/07/2026
Jessica Garlewicz
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized as a systemic inflammatory disease requiring management beyond cutaneous symptoms.
Psoriasis should be recognized...
10/07/2026
The Dermatologist
News
GLP-1 Receptor Agonists Linked to Lower Mortality, Cardiovascular Risk in Patients With Psoriasis
10/07/2026
Jessica Garlewicz
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor agonist treatment was associated with lower all-cause mortality and reduced cardiovascular and psychiatric comorbidity risks among patients with psoriasis and obesity or diabetes.
Glucagon-like peptide-1 receptor...
10/07/2026
The Dermatologist
News
Microbial Dysbiosis May Shape Psoriasis Pathogenesis Through the Gut-Skin Axis
10/07/2026
Jessica Garlewicz
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial dysbiosis may link genetic, immune, and environmental factors in psoriasis, with implications for personalized treatment.
A review suggests microbial...
10/07/2026
The Dermatologist
Smiling woman touching neck
News
Anatomy-Driven Model Aims to Prevent GLP-1 RA–Associated Facial Aging
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist

Popular Articles

Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
Riya Gandhi, MA
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies...
11/11/2024
The Dermatologist
acne
News
Topical Clindamycin: A Safe Choice for Acne Treatment Despite GI Concerns
10/31/2024
Riya Gandhi, MA
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
A recent review highlighted the...
10/31/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
Researcher-looking-through-microscope
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Advanced Therapeutic Sequencing and Personalized Care in Type 2 Inflammatory Skin Disease
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use